journal article·2026-12-31Open access

Prefrontal cortex-extracellular vesicle RNAs coupling in alcohol use disorder: towards non-invasive biomarkers and targeted therapeutics

Jie-quan Wang, Qing-rong Xia, Xuan Zhou, Chun-yu Yan, Wen-xiu Hong, Yi-yun Deng, Feng Shan, Ya-ru Liu, Jun Liang

Abstract

Alcohol use disorder (AUD) poses a substantial global health burden, with its molecular mechanism remaining elusive. This study integrated datasets (GSE253155, GSE180722, GSE182173 and GSE176122) and clinical specimens to identify non-invasive biomarkers and therapeutic candidates for AUD. Transcriptomic analysis of post-mortem prefrontal cortex identified 34 differentially expressed genes (DEGs), significantly enriched in TNF/IL-17 signalling, ribosome, cytokine-cytokine receptor interaction and endoplasmic reticulum protein processing. Among multiple machine learning algorithms, the support vector machine demonstrated superior classification performance, prioritizing MDK, FAM225B and SERPINA3 as critical biomarkers. These were incorporated into a highly predictive diagnostic nomogram. Intersection with plasma extracellular vesicle (EV) RNAs showed that all three biomarkers were detectable and upregulated in AUD patients versus controls, which was confirmed by quantitative real-time PCR (qRT-PCR) in a clinical validation cohort. SERPINA3 exhibited a particularly robust association with AUD, maintaining significance after adjustment for confounders and suggesting direct effects via mediation analysis. Cross-species validation confirmed a conserved dysregulation of murine Serpina3n. Computational drug repurposing identified loratadine, doxepin, citalopram and imipramine as promising therapeutic candidates targeting SERPINA3. Collectively, this work delineated PFC signature genes, proposed a EVs-supported brain–periphery molecular crosstalk, and provided translatable biomarkers and repurposable candidates for AUD precision medicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Alcohol Consumption and Health Effects · Alcoholism and Thiamine Deficiency

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Affiliated Psychological Hospital of Anhui Medical University

Department of Pharmacy, Hefei Fourth People’s Hospital

Psychopharmacology Research Laboratory, Anhui Mental Health Center

Anhui Clinical Research Center for Mental Disorders

Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University

The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine

Funding

National Natural Science Foundation of China · Scientific Research Foundation of Education Department of Anhui Province · Anhui Province Medical and Health Key Specialty Construction Project, Hefei Seventh Cycle Key Medical Specialty and Applied Medicine Research Project of Hefei

References (46)

Show source-provided references
1. 10.1016/S0140-6736(19)31775-110.1016/S0140-6736(19)31775-1 ↗
2. World Health Organization. Global status report on alcohol and health 2018. World Health Organization; Geneva 2019.
3. 10.1016/S2468-1253(24)00380-710.1016/S2468-1253(24)00380-7 ↗
4. 10.1111/add.1535710.1111/add.15357 ↗
5. 10.1097/MD.000000000001356610.1097/MD.0000000000013566 ↗
6. 10.1126/sciadv.aax404310.1126/sciadv.aax4043 ↗
7. 10.1007/s00535-017-1402-610.1007/s00535-017-1402-6 ↗
8. 10.1111/adb.1291510.1111/adb.12915 ↗
9. 10.1038/s41380-024-02777-110.1038/s41380-024-02777-1 ↗
10. 10.1016/j.bpsgos.2024.10037510.1016/j.bpsgos.2024.100375 ↗
11. 10.1172/jci.insight.17067110.1172/jci.insight.170671 ↗
12. 10.1007/s00213-015-3906-110.1007/s00213-015-3906-1 ↗
13. 10.1038/nrn311910.1038/nrn3119 ↗
14. 10.1038/s41380-024-02719-x10.1038/s41380-024-02719-x ↗
15. 10.1016/j.nbd.2023.10636110.1016/j.nbd.2023.106361 ↗
16. 10.1038/s41562-024-02040-110.1038/s41562-024-02040-1 ↗
17. 10.1016/j.biopha.2023.11435410.1016/j.biopha.2023.114354 ↗
18. 10.3389/fnmol.2022.103236210.3389/fnmol.2022.1032362 ↗
19. 10.1038/s41398-021-01635-w10.1038/s41398-021-01635-w ↗
20. 10.3389/fimmu.2023.111338510.3389/fimmu.2023.1113385 ↗
21. 10.1016/j.lfs.2021.11915110.1016/j.lfs.2021.119151 ↗
22. 10.1186/s12967-020-02698-x10.1186/s12967-020-02698-x ↗
23. 10.1186/s12911-025-02904-010.1186/s12911-025-02904-0 ↗
24. 10.1186/1471-2105-12-7710.1186/1471-2105-12-77 ↗
25. 10.7717/peerj.1543710.7717/peerj.15437 ↗
26. 10.1186/s12888-025-06514-y10.1186/s12888-025-06514-y ↗
27. 10.1097/HEP.000000000000087910.1097/HEP.0000000000000879 ↗
28. 10.2147/JIR.S41445210.2147/JIR.S414452 ↗
29. 10.7717/peerj.1923910.7717/peerj.19239 ↗
30. 10.3389/fimmu.2024.144346410.3389/fimmu.2024.1443464 ↗
31. 10.1093/nar/gkab108510.1093/nar/gkab1085 ↗
32. 10.1080/20013078.2018.156080910.1080/20013078.2018.1560809 ↗
33. 10.1186/s40364-023-00517-110.1186/s40364-023-00517-1 ↗
34. 10.1016/j.lfs.2024.12282010.1016/j.lfs.2024.122820 ↗
35. 10.1016/j.ijbiomac.2024.13939010.1016/j.ijbiomac.2024.139390 ↗
36. 10.1093/nar/gkac39410.1093/nar/gkac394 ↗
37. World Health Organization. Global status report on alcohol and health 2024. World Health Organization; Geneva 2024.
38. 10.1007/s40265-021-01670-310.1007/s40265-021-01670-3 ↗
39. 10.1016/j.ynstr.2023.10054010.1016/j.ynstr.2023.100540 ↗
40. 10.1111/adb.1314610.1111/adb.13146 ↗
41. 10.3389/fnins.2017.0027810.3389/fnins.2017.00278 ↗
42. 10.1002/ana.2517210.1002/ana.25172 ↗
43. 10.1126/scisignal.aai769610.1126/scisignal.aai7696 ↗
44. 10.1016/j.dadm.2018.11.00210.1016/j.dadm.2018.11.002 ↗
45. 10.1186/s13195-025-01865-w10.1186/s13195-025-01865-w ↗
46. 10.1038/s41398-025-03512-210.1038/s41398-025-03512-2 ↗